Effects of oxaliplatin and oleic acid Gc-protein-derived macrophage-activating factor on murine and human microglia

Journal of Neuroscience Research
Jacopo J V BrancaStefania Pacini

Abstract

The biological properties and characteristics of microglia in rodents have been widely described, but little is known about these features in human microglia. Several murine microglial cell lines are used to investigate neurodegenerative and neuroinflammatory conditions; however, the extrapolation of the results to human conditions is frequently met with criticism because of the possibility of species-specific differences. This study compares the effects of oxaliplatin and of oleic acid Gc-protein-derived macrophage-activating factor (OA-GcMAF) on two microglial cell lines, murine BV-2 cells and human C13NJ cells. Cell viability, cAMP levels, microglial activation, and vascular endothelial growth factor (VEGF) expression were evaluated. Our data demonstrate that oxaliplatin induced a significant decrease in cell viability in BV-2 and in C13NJ cells and that this effect was not reversed with OA-GcMAF treatment. The signal transduction pathway involving cAMP/VEGF was activated after treatment with oxaliplatin and/or OA-GcMAF in both cell lines. OA-GcMAF induced a significant increase in microglia activation, as evidenced by the expression of the B7-2 protein, in BV-2 as well as in C13NJ cells that was not associated with a concom...Continue Reading

References

May 1, 1990·Journal of Neuroimmunology·E BlasiF Bistoni
Mar 1, 1995·Journal of Neuropathology and Experimental Neurology·R De SimoneF Aloisi
Nov 3, 1998·Journal of Neurochemistry·K K Kopec, R T Carroll
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 8, 2002·Nature Reviews. Neuroscience·Minh Dang NguyenSerge Rivest
Jul 5, 2005·Nature Reviews. Neuroscience·Fabien MarchandStephen B McMahon
Jun 24, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sherry WolfCharles Loprinzi
Nov 4, 2008·Nature·Eric T WangChristopher B Burge
Nov 14, 2008·Biochemistry·Ekaterina L KnyazevaEugene A Permyakov
Dec 20, 2008·Nature Reviews. Neuroscience·Erin D Milligan, Linda R Watkins
Apr 3, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hiroaki WakeJunichi Nabekura
Oct 24, 2009·FEBS Letters·Tobias MaierLuis Serrano
Mar 12, 2013·Cellular and Molecular Life Sciences : CMLS·Tamar Licht, Eli Keshet
Aug 27, 2013·Methods in Molecular Biology·Jane Kovalevich, Dianne Langford
Sep 6, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Arjun ThapaEva Y Chi
Oct 19, 2013·The Journal of Pain : Official Journal of the American Pain Society·Lorenzo Di Cesare MannelliCarla Ghelardini
Nov 28, 2013·Toxicology Letters·Jonas Philipp BeckerDirk Theile
Jan 23, 2014·Journal of Neuroinflammation·Susana G Torres-PlatasNaguib Mechawar

❮ Previous
Next ❯

Citations

May 25, 2021·Frontiers in Molecular Biosciences·Jacopo Junio Valerio BrancaAlessandra Pacini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis